Search Results - "Giesa, P A"

An inactivated hepatitis A viral vaccine of cell culture origin by Provost, P J, Hughes, J V, Miller, W J, Giesa, P A, Banker, F S, Emini, E A

“…Hepatitis A virus (HAV) strain CR326, adapted to grow in LLC-MK2 cells, was highly purified, inactivated with formalin, adsorbed to alum, and tested for…”
Get more information

Progress toward a live, attenuated human hepatitis A vaccine by Provost, P J, Banker, F S, Giesa, P A, McAleer, W J, Buynak, E B, Hilleman, M R

Get more information

Studies in chimpanzees of live, attenuated hepatitis A vaccine candidates by Provost, P J, Conti, P A, Giesa, P A, Banker, F S, Buynak, E B, McAleer, W J, Hilleman, M R

“…Human hepatitis A virus was attenuated in virulence for chimpanzees by passage in FRhK6 and human diploid lung fibroblast cell cultures. A number of variants…”
Get more information

Development of the formalin-inactivated hepatitis A vaccine, VAQTA from the live attenuated virus strain CR326F by Armstrong, M E, Giesa, P A, Davide, J P, Redner, F, Waterbury, J A, Rhoad, A E, Keys, R D, Provost, P J, Lewis, J A

“…The development of the formalin-inactivated hepatitis A vaccine, VAQTA, culminates nearly two decades of the basic science studies of VAQTA in hepatitis A…”
Get more information

Isolation of hepatitis A virus in vitro in cell culture directly from human specimens by Provost, P J, Giesa, P A, McAleer, W J, Hilleman, M R

Get more information

Fetal rhesus kidney cells used for hepatitis A viral vaccine development are free from polyomavirus by Provost, P J, Giesa, P A, Buynak, E B, McLean, A A, Scolnick, E M

Get more information